Microvideos for Improving HPV Vaccination Among Childhood Cancer Survivors

NCT07648953 | Recruiting

• 1 other identifier: 198894
• Study Type: interventional
• Target: 55
• Locations: 1 country
• Sites: 1

Brief Summary

This exploratory mixed-methods study aims to examine receipt of treatment and decision-making among rural cancer patients in Utah. Guided by Conceptual Model of Healthcare Access, the study will integrate, survey and cancer registry data with patient interviews to better understand how travel burden, socioeconomic conditions, health literacy, and other contextual factors shape treatment location and access to care . While the setting of this research is specific to Utah, a state with vast rural regions and only one National Cancer Institute (NCI)-designated cancer center, the findings may inform policy and practice improvements in other states with similar geographic and healthcare infrastructure. Thus, the study has potential relevance for advancing rural cancer equity nationwide. Understanding how rural cancer patients make treatment decisions is essential to addressing persistent disparities in cancer care access and outcomes. While geographic barriers and structural inequities are well-documented, less is known about the individual and contextual factors that shape patients' choices about where and how to receive treatment. This mixed-methods study will examine receipt of treatment, decision-making, and patient experience among rural cancer patients in Utah, with attention to travel burden, referral pathways, health literacy, and perceived barriers to care.

Conditions

HPV Vaccination

Outcome Measures

Primary Outcomes (1)

• Feasibility of Microvideo education

  Feasibility will be defined as ≥80% of participants completing the intervention and study surveys.

  up to 4 weeks

Secondary Outcomes (3)

• Acceptability of Microvideo Education

  up to 4 weeks

• Satisfaction Acceptability of Microvideo Education

  up to 4 weeks

• HPV Vaccine Intention

  up to 4 weeks

Study Arms (1)

HPV Vaccination Education

OTHER

Microvideos are designed to be \<2 minutes long and to address key information on a topic in an engaging and concise manner. HPV vaccine education will be provided to unvaccinated emerging adult survivors of childhood cancer through a pilot quasi-experimental social media intervention.

Behavioral: Microvideos: HPV Vaccination Education

Interventions

Microvideos: HPV Vaccination Education BEHAVIORAL

To educate survivors of childhood cancers about a key cancer prevention strategy, HPV vaccination. The core microvideos will focus on the 5 Ws of HPV vaccination: Who should get vaccinated, What HPV vaccination protects against, When to get vaccinated, Where to access the vaccine, Why it matters-designed particularly for cancer survivors.

HPV Vaccination Education

Eligibility Criteria

• Age: 18 Years - 26 Years
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64)

You may qualify if:

• Eligible participants include cancer survivors who are currently ages 18-26 years and who were diagnosed with childhood cancer (ages 0-26 at diagnosis) in the past ten years.
• Currently use Facebook or willing to create a Facebook account to use for the duration of the study.
• At the time of enrollment, have not completed all recommended doses of the HPV vaccine.

You may not qualify if:

• Unable to speak and understand English.
• Participants who take part in the Aim 1 focus groups will be ineligible for the Aim 2 social media group.
• Participants who are fully vaccinated for HPV will be ineligible as the goal of Aim 2 is to evaluate the feasibility of the social media campaign for improving vaccine intention among HPV unvaccinated individuals.

Sponsors & Collaborators

• University of Utah: lead
• Prevent Cancer Foundation: collaborator
• Huntsman Cancer Institute: collaborator

Study Sites (1)

University of Utah

Salt Lake City, Utah, 84112, United States

RECRUITING

Study Officials

• Echo Warner, MPH, PhD, SB

  Huntsman Cancer Institute/ University of Utah

  PRINCIPAL INVESTIGATOR

Central Study Contacts

Echo Warner, MPH, PhD, SB

CONTACT

801-244-7040; echo.warner@hci.utah.edu

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: NA
• Masking: NONE
• Purpose: PREVENTION
• Intervention Model: SINGLE GROUP
• Sponsor Type: OTHER
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: May 27, 2026
• First Posted: June 15, 2026
• Study Start (Estimated): July 1, 2026
• Primary Completion (Estimated): May 1, 2027
• Study Completion (Estimated): May 1, 2027
• Last Updated: June 15, 2026

Record last verified: 2026-05

Data Sharing

• IPD Sharing: Will not share

Locations

US (1)